Stockreport

Mirum Pharmaceuticals: Rich In 2025, Richer (In Promise) In 2026? I Believe So [Seeking Alpha]

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF MIRM's commercial products are projected to generate $500–510m in 2025, led by Livmarli, with strong year-on-year revenue growth and upgraded guidance. The Bluejay Th [Read more]